Cargando…

The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia

The identification of new pathways supporting the myelodysplastic syndrome (MDS) primitive cells growth is required to develop targeted therapies. Within myeloid malignancies, men have worse outcomes than women, suggesting male sex hormone–driven effects in malignant hematopoiesis. Androgen receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karantanos, Theodoros, Teodorescu, Patric, Perkins, Brandy, Christodoulou, Ilias, Esteb, Christopher, Varadhan, Ravi, Helmenstine, Eric, Rajkhowa, Trivikram, Paun, Bogdan C., Bonifant, Challice, Dalton, W. Brian, Gondek, Lukasz P., Moliterno, Alison R., Levis, Mark J., Ghiaur, Gabriel, Jones, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2022
Materias:	Biomedicine and Life Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856621/ https://www.ncbi.nlm.nih.gov/pubmed/35179961 http://dx.doi.org/10.1126/sciadv.abl8952

Ejemplares similares

CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
por: Karantanos, Theodoros, et al.
Publicado: (2022)

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
por: Gerke, Margo B., et al.
Publicado: (2023)

From cell surface to nucleus: CCRL2 regulates response to hypomethylating agents in myelodysplastic syndromes
por: Saygin, Caner
Publicado: (2023)

Molecular Basis for CCRL2 Regulation of Leukocyte Migration
por: Schioppa, Tiziana, et al.
Publicado: (2020)

Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
por: Christodoulou, Ilias, et al.
Publicado: (2021)

Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
por: Zavras, Phaedon D., et al.
Publicado: (2023)

CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment
por: Christodoulou, Ilias, et al.
Publicado: (2021)

OsCCRL1 is Essential for Phenylpropanoid Metabolism in Rice Anthers
por: Zhang, Lisha, et al.
Publicado: (2023)

Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
por: Christodoulou, Ilias, et al.
Publicado: (2021)

Atypical chemokine receptor CCRL2 is overexpressed in prostate cancer cells
por: Reyes, Niradiz, et al.
Publicado: (2019)

CCRL2 Modulates Physiological and Pathological Angiogenesis During Retinal Development
por: Ben Dhaou, Cyrine, et al.
Publicado: (2021)

Exploring CCRL2 chemerin binding using accelerated molecular dynamics
por: Bufano, Marianna, et al.
Publicado: (2022)

Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and CCRL2
por: De Henau, Olivier, et al.
Publicado: (2016)

Expression of CCRL2 Inhibits Tumor Growth by Concentrating Chemerin and Inhibiting Neoangiogenesis
por: Al Delbany, Diana, et al.
Publicado: (2021)

The Coming of Age of Preclinical Models of MDS
por: Liu, Wei, et al.
Publicado: (2022)

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation
por: Gondek, Lukasz P., et al.
Publicado: (2016)

Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo
por: Regan-Komito, Daniel, et al.
Publicado: (2017)

Epitope tagging of endogenous genes in diverse human cell lines
por: Kim, Jung-Sik, et al.
Publicado: (2008)

Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration
por: Jain, Tania, et al.
Publicado: (2023)

Ccrl2 deficiency deteriorates obesity and insulin resistance through increasing adipose tissue macrophages infiltration
por: Xu, Min, et al.
Publicado: (2020)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

Human Immunodeficiency Virus and Clonal Hematopoiesis
por: Vorri, Stamatia C., et al.
Publicado: (2023)

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
por: Jain, Tania, et al.
Publicado: (2023)

Development of a large-scale isolation chamber system for the safe and humane care of medium-sized laboratory animals harboring infectious diseases
por: Pan, Xin, et al.
Publicado: (2010)

Distributions of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populations
por: Zhu, Bo-feng, et al.
Publicado: (2010)

Sporadic Creutzfeldt–Jakob disease subtype-specific alterations of the brain proteome: Impact on Rab3a recycling
por: Gawinecka, Joanna, et al.
Publicado: (2012)

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone*
por: She, Yi-Min, et al.
Publicado: (2013)

Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues
por: Steiner, Carine, et al.
Publicado: (2014)

MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis
por: Winter, Martin, et al.
Publicado: (2017)

Binodal, wireless epidermal electronic systems with in-sensor analytics for neonatal intensive care
por: Chung, Ha Uk, et al.
Publicado: (2019)

Proteomics insights into DNA damage response and translating this knowledge to clinical strategies
por: von Stechow, Louise, et al.
Publicado: (2016)

Proteomic characterization of microdissected breast tissue environment provides a protein‐level overview of malignant transformation
por: Braakman, René B. H., et al.
Publicado: (2017)

A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
por: Lee, Lauren Y., et al.
Publicado: (2021)

Comparative modeling of CCRL1, a key protein in masked immune diseases and virtual screening for finding inhibitor of this protein
por: Behjati, Mohaddeseh, et al.
Publicado: (2012)

Role of Exonic Variation in Chemokine Receptor Genes on AIDS: CCRL2 F167Y Association with Pneumocystis Pneumonia
por: An, Ping, et al.
Publicado: (2011)

A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML
por: Ambinder, Alexander J., et al.
Publicado: (2020)

Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study
por: Karantanos, Theodoros, et al.
Publicado: (2020)

Work efficiency improvement of >90% after implementation of an annual inpatient blood products administration consent form
por: Lindsay, Holly, et al.
Publicado: (2018)

The Atypical Receptor CCRL2 (C-C Chemokine Receptor-Like 2) Does Not Act As a Decoy Receptor in Endothelial Cells
por: Mazzotti, Chiara, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v92nl8voknes2dj8e7rdcnpuio